PRCM
ONC

Pine River Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Pine River Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-61,509
Closed -$1.87M – 360
2016
Q4 		$1.87M Hold
61,509
– – 0.07% 117
2016
Q3 		$1.9M Sell
61,509
-3,200
-5% -$92.9K 0.03% 157
2016
Q2 		$1.93M Hold
64,709
– – 0.02% 187
2016
Q1 		$1.9M Buy
+64,709
New +$1.83M 0.03% 234

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Pine River Capital Management's ONC Position: Q1 2017 in Review

Pine River Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2017, closing a stake of 61,509 shares — an estimated $1.87M sold.

Pine River Capital Management first reported a position in ONC in Q1 2016 and held it in 4 quarters. The position peaked at $1.93M in Q2 2016. 56 funds tracked by Wall St. Rank hold ONC as of Q1 2017.

  • Pine River Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2017 after selling out during the quarter.
  • Pine River Capital Management sold 61,509 BeOne Medicines Ltd shares in Q1 2017, an estimated $1.87M.
  • Pine River Capital Management first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 4 quarters.
  • Pine River Capital Management's BeOne Medicines Ltd position peaked at $1.93M in Q2 2016.
  • 56 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2017.

Based on Pine River Capital Management's 13F filing for Q1 2017, filed 15 May 2017.